Preferred Name |
mirabegron |
|
Synonyms |
YM-178 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C520025 |
|
altLabel |
YM-178 Betmiga Betanis 2-(2-aminothiazol-4-yl)-4'-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)acetanilide YM 178 |
|
cui |
C3489691 C1957299 C2983812 |
|
HM |
D013844 D000083 |
|
Inverse of RB |
MVR3JL3B2V |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20070603 |
|
MeSH Frequency |
522 |
|
MMR |
20160321 |
|
notation |
C520025 |
|
PA |
D058667 D064804 |
|
prefLabel |
mirabegron |
|
SC |
1 |
|
Scope Statement |
a beta3-adrenergic receptor agonist; structure in first source |
|
SRC |
J Pharmacol Exp Ther 2007 May;321(2):642-7 |
|
TERMUI |
T698813 T821868 T792324 T000897433 T698812 T698811 |
|
TH |
NLM (2016) NLM (2012) USAN (19XX) INN (19XX) NLM (2007) NLM (2011) |
|
tui |
T109 T121 |
Create mapping